Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Detection of Small Early Liver Cancer With Natural History Follow up
Sponsor: University of Oxford
Summary
The SELINA study will recruit 200 patients with cirrhosis and small HCC and 50 patients with HCC but without cirrhosis (most of whom are expected to have FLD). Blood, urine and liver tissue samples (where available) will be collected for laboratory analysis. In a subgroup of patients (N=80, around 64 patients with HCC with liver cirrhosis and around 16 patients with HCC without liver cirrhosis), additional magnetic resonance liver imaging will be performed. The findings of the SELINA study aim to identify biomarkers that can be used to detect liver cancer at the earliest possible time, something we expect will increase the survival rate of HCC.
Key Details
Gender
All
Age Range
18 Years - 100 Years
Study Type
OBSERVATIONAL
Enrollment
250
Start Date
2022-05-23
Completion Date
2035-06
Last Updated
2022-09-10
Healthy Volunteers
No
Conditions
Interventions
Blood & Urine Samples
Blood and urine samples will be collected to help identify biomarkers that can be used to detect liver cancer at the earliest possible time
Imaging
MRI \& MRE Scans
Locations (1)
Hepatology Clinical Trial Unit, John Radcliffe Hospital
Oxford, Oxfordshire, United Kingdom